Cellgen

Cellgen has developed a diagnostic platform that enables precision medicine. We don't make the medicine patients take, we make the medicine patients take work.

[Alex Garcia 🔍 @alexgarcia_atx]

ChatGPT will save your marketing team time and money if you know how to use it.

Here are 7 ways ChatGPT can power your marketing team in 2023:

[Cellgen @CellgenDx]

Cellgen Diagnostics and Genomic Testing Cooperative Partner to Establish a New Standard in Co-Development of Companion Diagnostics for Cancer Therapies | Business Wire https://t.co/osNdiRbn0b

[Cellgen @CellgenDx]

2018 Nobel Prize in Medicine awarded to researchers for cancer breakthrough https://t.co/lc0bqm8bbc

[Cellgen @CellgenDx]

Companion diagnostics beyond oncology https://t.co/9D5bYJezet via @BioPharmaDive

[Cellgen @CellgenDx]

Agilent (A) Gets FDA Approval for Cervical Cancer Test Assay - June 14, 2018 - https://t.co/gZn5l7x30u https://t.co/uqvDmF4UoG

[Cellgen @CellgenDx]

Payers Starting to Tie Precision Medicine to Value-Based Care https://t.co/nC6UzMsNID

[Cellgen @CellgenDx]

In a precision medicine landmark, FDA approves first gene therapy https://t.co/8FPbursBFK via @HealthITNews

[Cellgen @CellgenDx]

Cancer Breakthroughs Can Quickly Become Tomorrow's Also-Ran https://t.co/3Ls7mFtP25 via @technology

[Cellgen @CellgenDx]

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients https://t.co/SFZgyEggFN

[Cellgen @CellgenDx]

Konica and Ambry Pairing to Accelerate Precision Medicine https://t.co/iSy3cPYgcl via @TheStreet

[Cellgen @CellgenDx]

Why the immune system is our best bet to battle cancer https://t.co/qHu771co2p

[Cellgen @CellgenDx]

Wall Street may want too much, too soon, from CAR-T drugs https://t.co/YykqjxFoYW via @BW

[Cellgen @CellgenDx]

An FDA Panel Just Approved A Treatment That Genetically Alters Your Own Cells https://t.co/9YLFEotAUJ via @Futurism

[Cellgen @CellgenDx]

https://t.co/08FCynri0D

[Cellgen @CellgenDx]

Bedside drug production will truly enable personalized medicine https://t.co/QQis9DDEny via @statnews

[Cellgen @CellgenDx]

Good news for the precision medicine community: FDA Approved Cancer Drug Based on Mutation, Not Location https://t.co/pWlWuIwH8r @LabRoots

[Cellgen @CellgenDx]

Silicon Valley VCs are tripping over themselves to hire biotech experts https://t.co/Q2nwDptrwo

[Cellgen @CellgenDx]

21st Century Medicine: Where Big Tech Is Placing Bets In Healthcare https://t.co/FFWM1xJEsC via @cbinsights

[Eric Topol @EricTopol]

The current landscape of RNA targeted drugs https://t.co/jvA30uXqEV by @scchak @NatureMedicine

[Cellgen @CellgenDx]

Global artificial intelligence in health care market to hit almost $8 billion in 2022 https://t.co/SYdDHif2S9 #HCBNews via @DOTmedcom